PGE(2) in the regulation of programmed erythrocyte death

Cell Death Differ. 2005 May;12(5):415-28. doi: 10.1038/sj.cdd.4401561.

Abstract

Hyperosmotic shock, energy depletion, or removal of extracellular Cl(-) activates Ca(2+)-permeable cation channels in erythrocyte membranes. Subsequent Ca(2+) entry induces erythrocyte shrinkage and exposure of phosphatidylserine (PS) at the erythrocyte surface. PS-exposing cells are engulfed by macrophages. The present study explored the signalling involved. Hyperosmotic shock and Cl(-) removal triggered the release of prostaglandin E(2) (PGE(2)). In whole-cell recording, activation of the cation channels by Cl(-) removal was abolished by the cyclooxygenase inhibitor diclophenac. In FACS analysis, phospholipase-A(2) inhibitors quinacrine and palmitoyltrifluoromethyl-ketone, and cyclooxygenase inhibitors acetylsalicylic acid and diclophenac, blunted the increase of PS exposure following Cl(-) removal. PGE(2) (but not thromboxane) induced cation channel activation, increase in cytosolic Ca(2+) concentration, cell shrinkage, PS exposure, calpain activation, and ankyrin-R degradation. The latter was attenuated by calpain inhibitors-I/II, while PGE(2)-induced PS exposure was not. In conclusion, hyperosmotic shock or Cl(-) removal stimulates erythrocyte PS exposure through PGE(2) formation and subsequent activation of Ca(2+)-permeable cation channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ankyrins / metabolism
  • Annexins / metabolism
  • Apoptosis / drug effects*
  • Calcium / metabolism
  • Calcium Channels / drug effects
  • Calpain / metabolism
  • Cell Size / drug effects
  • Chlorides / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytosol / drug effects
  • Diclofenac / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Erythrocytes / drug effects*
  • Flow Cytometry
  • Humans
  • Models, Biological
  • Osmotic Pressure / drug effects
  • Patch-Clamp Techniques
  • Phosphatidylserines / metabolism
  • Phospholipases A / metabolism
  • Prostaglandins E / metabolism*
  • Prostaglandins E / pharmacology
  • Quinacrine / pharmacology
  • Saline Solution, Hypertonic

Substances

  • Ankyrins
  • Annexins
  • Calcium Channels
  • Chlorides
  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Phosphatidylserines
  • Prostaglandins E
  • Saline Solution, Hypertonic
  • Diclofenac
  • Phospholipases A
  • Calpain
  • Quinacrine
  • Calcium